Even general practitioners, and no longer just specialists, will be able to prescribe the best possible treatment to all patients with type 2 diabetes, no longer based on the mere correction of glycaemia, but on the prevention of cardiovascular and renal complications which represent important critical issues. of this pathology.
It is the result of the “Note 100”, a provision of the AIFA, the Italian Medicines Agency, which allows the prescription of 3 categories of important drugs for the treatment of diabetes and its complications: Sglt2 inhibitors, Glp1 receptor agonists and Dpp4 inhibitors.
With the introduction of Note 100, a large number of medicinal specialties, also in association, can therefore be prescribed directly by the general practitioner, as well as by all the specialists of the National Health Service (SSN). This is a much awaited step, required by both patient associations and doctors, which will allow General Practitioner to acquire a primary role in the integrated management of diabetes.
Type 2 diabetes mellitus represents a chronic disease with a growing prevalence: it affects 6-7% of Italians (over 3.5 million patients), and has a significant impact in terms of morbidity and mortality. About one third of patients are followed exclusively by the general practitioner who, however, was not authorized to prescribe these active ingredients until now. (HANDLE).
breaking latest news © Copyright ANSA